Paper Details
- Home
- Paper Details
Dopamine Transporter Dynamics of <i>N</i>-Substituted Benztropine Analogs with Atypical Behavioral Effects.
Author: HayashiShuichiro, HiranitaTakato, HongWeimin C, KatzJonathan L, LiLibin, MaduraJeffry D, SnellDavid B, SurrattChristopher K, WaskoMichael J, WilkinsonDerek S
Original Abstract of the Article :
Atypical dopamine transporter (DAT) inhibitors, despite high DAT affinity, do not produce the psychomotor stimulant and abuse profile of standard DAT inhibitors such as cocaine. Proposed contributing features for those differences include off-target actions, slow onsets of action, and ligand bias re...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102189/
データ提供:米国国立医学図書館(NLM)
Unraveling the Mystery of Dopamine Transporter Dynamics
The world of dopamine transporters (DATs) is a fascinating one, and researchers are constantly working to unravel the mysteries surrounding their function. DATs are responsible for the reuptake of dopamine, a neurotransmitter crucial for movement, motivation, and reward. In this research, the team focuses on the dynamics of DATs in the context of atypical dopamine transporter inhibitors, a category of drugs that have a unique profile compared to standard DAT inhibitors like cocaine. These atypical inhibitors, despite their high affinity for DATs, don't trigger the same psychomotor stimulant effects or potential for abuse as cocaine. The study delves into this difference by examining the actions of various 3α-(4',4''-difluoro-diphenylmethoxy)tropanes, a class of compounds known for their rapid onset of behavioral effects. This research, using a combination of experimental techniques and molecular dynamics simulations, sheds light on the unique conformations of DATs induced by these atypical inhibitors, ultimately providing valuable insights for the development of potential treatments for psychomotor stimulant abuse.
Unlocking the Secrets of DAT Conformations
This research reveals that atypical DAT inhibitors, unlike cocaine, stabilize the DAT in a conformation that favors the cytoplasmic side, effectively preventing dopamine from being released into the synaptic cleft. This fascinating finding suggests that the specific conformation of DATs induced by these inhibitors plays a critical role in their atypical behavioral effects.
Implications for the Future of Addiction Treatment
The implications of this research extend beyond the realm of basic science, reaching into the realm of addiction treatment. This research suggests that understanding DAT conformations is key to predicting the actions of DAT inhibitors and could pave the way for the development of novel therapeutic interventions for psychomotor stimulant abuse. By targeting specific conformations of DATs, researchers could potentially develop drugs that effectively block the rewarding effects of cocaine while minimizing unwanted side effects.
Dr. Camel's Conclusion
This research is a valuable contribution to our understanding of DAT dynamics and its relevance in addiction. It's like studying the intricate dance of a camel caravan across the vast desert, where every subtle movement and interaction can influence the overall journey. Understanding the intricacies of DAT conformations could ultimately lead to a new generation of drugs that effectively combat the scourge of psychomotor stimulant abuse.
Date :
- Date Completed 2019-07-29
- Date Revised 2019-07-29
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.